Cargando…
Broncho-Vaxom Attenuates Allergic Airway Inflammation by Restoring GSK3β-Related T Regulatory Cell Insufficiency
BACKGROUND: Oral administration of bacterial extracts (eg, Broncho-Vaxom (BV)) has been proposed to attenuate asthma through modulating Treg cells. However, the underlying mechanism has not been fully characterized. This study sought to assess the effects of oral administration of BV on GSK-3β expre...
Autores principales: | Fu, Ran, Li, Jian, Zhong, Hua, Yu, Dehong, Zeng, Xianping, Deng, Mengxia, Sun, Yueqi, Wen, Weiping, Li, Huabin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965496/ https://www.ncbi.nlm.nih.gov/pubmed/24667347 http://dx.doi.org/10.1371/journal.pone.0092912 |
Ejemplares similares
-
Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023) -
Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP
por: Roth, Michael, et al.
Publicado: (2017) -
OM-85 Broncho-Vaxom(®), a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
por: Fang, Lei, et al.
Publicado: (2021) -
Allergic Broncho Pulmonary Aspergillosis Complicated by Nocardiosis
por: Sharma, Brijesh, et al.
Publicado: (2012) -
Broncho-Pneumonia
Publicado: (1906)